FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a material for implanted medical devices. The material represents a conjugate containing a biocompatible, bioabsorbable corrugated PVA-PLA copolymer containing hydrophilic antithrombotic terminal groups of heparin.
EFFECT: corrugated antithrombotic conjugate may be applied on a surface of an implanted medical device to prevent thrombosis in place of arranging the device and counteracting restenosis.
6 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ELUTING STENT WITH CONTAINERS | 2010 |
|
RU2541753C2 |
| STENT WITH DOUBLE DRUG RELEASE | 2010 |
|
RU2552086C2 |
| ADHESION-STIMULATING TEMPORARY MASK FOR COATED SURFACES | 2009 |
|
RU2526885C2 |
| RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
| PRIMER-ADHESION PROMOTER FOR SURFACES WITH COATING | 2009 |
|
RU2522390C2 |
| LOCAL DELIVERY OF COMBINATION OF ADENOSINE A2A RECEPTOR AGONISTS/PHOSPHODIESTERASE INHIBITOR IN VESSELS TO RELIEVE MYOCARDIAL INVOLVEMENT SEVERITY | 2011 |
|
RU2565403C2 |
| BARE METAL STENT WITH MEDICATION-RELEASING RESERVOIRS | 2011 |
|
RU2573107C2 |
| DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
| RESUMPTION OF BLOOD FLOW IN HUMAN BLOCKED ARTERIES BY TRANSFERRING NANO INCAPSULATED DRUG BY MEANS OF MEDICAL DEVICES DESIGNED THEREFOR, AND RELEASE OF NANO INCAPSULATED DRUG WITHIN HUMAN ARTERY AT PHYSIOLOGIC pH LEVEL | 2010 |
|
RU2605793C2 |
| METHOD OF PRODUCING BIOCOMPATIBLE COMPOSITE MATERIAL WITH NANOSTRUCTURE TITANIUM NICKELIDE BASE AND BIODEGRADABLE DRUG-CONTAINING POLYLACTIDE WITH HEPARIN | 2019 |
|
RU2737827C1 |
